US Patent 7514417 A
Patent 7514417 was granted and assigned to Cv Therapeutics on April, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+136 characters)
Article
Patent abstract
Disclosed are novel compounds that are partial and full A1 adenosine receptor agonists having the structure of Formula I:
Edits on 6 Aug, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
75144170
Date of Patent
April 7, 2009
0Patent Application Number
114372420
Date Filed
May 19, 2006
0Patent Primary Examiner
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07514417 A US Patent 7514417 A
Infobox
Patent Number
0751441700
Patent Number
751441700
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075144170
Date of Patent
April 7, 2009
0Patent Application Number
114372420
Date Filed
May 19, 2006
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075144170
Date of Patent
April 7, 2009
0Patent Application Number
114372420
Date Filed
May 19, 2006
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07514417 A
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07514417
Date of patent
April 7, 2009
Patent application number
11437242
Date Filed
May 19, 2006
Patent primary examiner
Find more entities like US Patent 7514417 A
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.